The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine

Schizophrenia has a considerable genetic background. Epidemiological studies suggest an inverse clinical association between schizophrenia and migraine. However, it is unclear to what extent this inverse comorbidity can be explained by genetic mechanisms or by schizophrenia-related behavioral factor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Auwera, Sandra van der (VerfasserIn) , Rietschel, Marcella (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 July 2016
In: European neuropsychopharmacology
Year: 2016, Jahrgang: 26, Heft: 9, Pages: 1507-1515
ISSN:1873-7862
DOI:10.1016/j.euroneuro.2016.03.019
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.euroneuro.2016.03.019
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0924977X16300177
Volltext
Verfasserangaben:Sandra Van der Auwera, Alexander Teumer, Johannes Hertel, Georg Homuth, Uwe Völker, Michael J. Lucht, Franziska Degenhardt, Thomas Schulze, Marcella Rietschel, Markus M. Nöthen, Ulrich John, Matthias Nauck, Hans Jörgen Grabe

MARC

LEADER 00000caa a2200000 c 4500
001 1568638469
003 DE-627
005 20220814070428.0
007 cr uuu---uuuuu
008 180208s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.euroneuro.2016.03.019  |2 doi 
035 |a (DE-627)1568638469 
035 |a (DE-576)498638464 
035 |a (DE-599)BSZ498638464 
035 |a (OCoLC)1340986362 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Auwera, Sandra van der  |d 1988-  |e VerfasserIn  |0 (DE-588)1123590699  |0 (DE-627)877004501  |0 (DE-576)481826610  |4 aut 
245 1 4 |a The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine  |c Sandra Van der Auwera, Alexander Teumer, Johannes Hertel, Georg Homuth, Uwe Völker, Michael J. Lucht, Franziska Degenhardt, Thomas Schulze, Marcella Rietschel, Markus M. Nöthen, Ulrich John, Matthias Nauck, Hans Jörgen Grabe 
264 1 |c 6 July 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.02.2018 
520 |a Schizophrenia has a considerable genetic background. Epidemiological studies suggest an inverse clinical association between schizophrenia and migraine. However, it is unclear to what extent this inverse comorbidity can be explained by genetic mechanisms or by schizophrenia-related behavioral factors. For both disorders hypotheses of glutamate N-methyl-D-aspartate (NMDA) receptor dysfunction have been developed in the past. We hypothesized that both conditions share common genetic factors with inverse effects, primary in the glutamatergic system and genes involved in NMDA activation. Data from the population based Study of Health in Pomerania (N=3973) were used. Based on the results from the recent genome-wide association study for schizophrenia, we calculated polygenic scores (PRS) for subsets of SNPs with different p-value cutoffs and for biological sub-entities. These scores were tested for an association of distinct biological pathways with migraine. The PRS for schizophrenia was inversely associated with migraine in our sample. This association was exclusively based on the genome-wide hits and on single nucleotide polymorphisms near or within genes encoding proteins involved in glutamatergic neurotransmission. This association could be attributed to a single intronic variant rs4523957 in SRR encoding serine-racemase. Additional expression quantitative trait loci analyses of functional variants in SRR and gene-by-gene interaction analyses further supported the validity of this finding. SRR represents the rate limiting enzyme for the synthesis of D-serine, an important co-agonist of the NMDA receptor. According to our results, a decreased versus increased activation of NMDA receptors may play a role in the etiology of schizophrenia, as well as in migraine. 
650 4 |a D-serine 
650 4 |a Migraine 
650 4 |a NMDA hypo-/hyperactivation 
650 4 |a Schizophrenia 
650 4 |a Serine-racemase 
700 1 |a Rietschel, Marcella  |d 1957-  |e VerfasserIn  |0 (DE-588)112785751  |0 (DE-627)505574020  |0 (DE-576)289742307  |4 aut 
773 0 8 |i Enthalten in  |t European neuropsychopharmacology  |d Amsterdam : Elsevier, 1990  |g 26(2016), 9, Seite 1507-1515  |h Online-Ressource  |w (DE-627)320594025  |w (DE-600)2019305-1  |w (DE-576)266224334  |x 1873-7862  |7 nnas  |a The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine 
773 1 8 |g volume:26  |g year:2016  |g number:9  |g pages:1507-1515  |g extent:9  |a The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine 
856 4 0 |u http://dx.doi.org/10.1016/j.euroneuro.2016.03.019  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0924977X16300177  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180208 
993 |a Article 
994 |a 2016 
998 |g 112785751  |a Rietschel, Marcella  |m 112785751:Rietschel, Marcella  |d 60000  |e 60000PR112785751  |k 0/60000/  |p 9 
999 |a KXP-PPN1568638469  |e 2996661125 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Sandra Van der Auwera, Alexander Teumer, Johannes Hertel, Georg Homuth, Uwe Völker, Michael J. Lucht, Franziska Degenhardt, Thomas Schulze, Marcella Rietschel, Markus M. Nöthen, Ulrich John, Matthias Nauck, Hans Jörgen Grabe"]},"id":{"eki":["1568638469"],"doi":["10.1016/j.euroneuro.2016.03.019"]},"origin":[{"dateIssuedDisp":"6 July 2016","dateIssuedKey":"2016"}],"relHost":[{"disp":"The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serineEuropean neuropsychopharmacology","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 31.01.20"],"language":["eng"],"recId":"320594025","pubHistory":["1.1990/91 -"],"titleAlt":[{"title":"ENP"}],"part":{"pages":"1507-1515","issue":"9","year":"2016","extent":"9","text":"26(2016), 9, Seite 1507-1515","volume":"26"},"title":[{"title":"European neuropsychopharmacology","subtitle":"ENP ; the journal of the European College of Neuropsychopharmacology","title_sort":"European neuropsychopharmacology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam","dateIssuedDisp":"1990-","publisher":"Elsevier","dateIssuedKey":"1990"}],"id":{"eki":["320594025"],"zdb":["2019305-1"],"issn":["1873-7862"]}}],"physDesc":[{"extent":"9 S."}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Auwera, Sandra van der","given":"Sandra van der","family":"Auwera"},{"family":"Rietschel","given":"Marcella","display":"Rietschel, Marcella","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title_sort":"inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine","title":"The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine"}],"recId":"1568638469","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 08.02.2018"]} 
SRT |a AUWERASANDINVERSELIN6201